Pediatric Interventional Cardiology Market Size, Growth, Report and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global pediatric interventional cardiology market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the Pediatric Interventional Cardiology market?

The global pediatric interventional cardiology market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

What is Pediatric Interventional Cardiology?

Pediatric interventional cardiology refers to the treatment and diagnosis of congenital heart defects in children by utilizing cardiac catheterization. It involves placing a small, flexible and hollow catheter into the blood vessel and threading it through the vessel into the heart to carry out multiple tests. It provides various opportunities to surgeons for conducting minimally invasive surgeries (MIS) and measure aspects, such as blood pressure, oxygen levels in the blood, and flow of blood, to examine the structure of the heart and treat a wide range of congenital heart defects.

Request Free Sample Copy of This Report:

What are the growth prospects and trends in the pediatric interventional cardiology industry?

At present, the increasing demand for pediatric interventional cardiology as an alternative to open heart surgeries represents one of the primary factors supporting the growth of the market. Besides this, the rising construction of hospitals, nursing homes, and clinics to provide quality healthcare facilities to patients is propelling the growth of the market.

In addition, the growing advancements made in medical science to improve the treatment and diagnosis of various life-threatening diseases are offering a favorable market outlook. Apart from this, the increasing adoption of minimally invasive (MI) surgical methods to reduce scarring and recovery duration and minimize hospital expenses is contributing to the growth of the market.

Additionally, the rising occurrence of various congenital cardiac complications in children, such as atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA) due to genetic instabilities and adoption of unhealthy lifestyle habits during pregnancy is bolstering the growth of the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Device Type:

  • Closure Devices
  • Transcatheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Balloons
  • Stents
  • Others

Breakup by Procedure:

  • Catheter-Based Valve Implantation
  • Congenital Heart Defect Correction
  • Angioplasty
  • Coronary Thrombectomy
  • Others

Breakup by End Use:

  • Clinical Testing Laboratories
  • Hospitals
  • Cardiac Centers
  • Pediatric Clinics
  • Research Institutions

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including: 

Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal


Global Solvent Market Size, Share, Industry Trends & Forecast 2023-2028

Leave a Reply

Your email address will not be published. Required fields are marked *